79However, it cannot be presumed that an agreement or a concerted practice whereby undertakings exchange information which is commercially sensitive but which relates to a product sold on a market on which they are not competitors has an anti-competitive object or effect on that market. A practice whereby an undertaking which is active on two distinct product markets provides to its competitors – which are present on one market – commercially sensitive information which relates to a second market – on which those competitors are not present – is not capable, in principle, of having an impact on competition on the second market.